Thyrozol

Medicinal product

(Invented) name

Thyrozol

Active substance (s)

Tiamazolas

Strength

5 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

H03BB02, Thiamazole

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2026-01-22

Date of renewal

Documents

3149_Thyrozol 5mg_pl_deng_tab_PL_2026-01-22.docx

3149_Thyrozol 5mg_pl_deng_tab_PZ_2026-01-22.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Tiamazolas	5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
119901	106007	1106007	lizdinė plokštelė	N30		Receptinis	LT/L/26/3149/001	Netiekiama	-	2026-04-01	No	-	-	Download
119902	106008	1106008	lizdinė plokštelė	N60		Receptinis	LT/L/26/3149/002	Netiekiama	-	2026-04-01	No	-	-

Stadijos

Data	Stadija
2026-01-22	Registruotas